Xiwen Zhang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database.
Journal: Frontiers in immunology
Published: January 22, 2025
The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database.
Journal: Frontiers in immunology
Published: November 30, 2024
Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis in vitro and in a mouse model of recessive dystrophic epidermolysis bullosa.
Journal: Burns & trauma
Published: November 18, 2024
Autoimmune Bullous Disease Combined With Acquired Hemophilia A: A Systematic Review and Case Analysis.
Journal: The Journal of dermatology
Published: November 14, 2024
Autoimmune bullous diseases: pathogenesis and clinical management.
Journal: Molecular biomedicine
Published: August 13, 2024
Treatment with immunosuppressants did not increase the risk of COVID-19 in pemphigus patients: A single-center survey-based study.
Journal: International immunopharmacology
Published: February 29, 2024
Single-Cell Transcriptome Analysis Reveals Interaction between CCL19+ Inflammatory Keratinocytes and CCR7+ Dendritic Cells and B Cells in Pemphigus.
Journal: The Journal of investigative dermatology
Published: November 03, 2023
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.
Journal: The Journal of dermatology
Published: September 15, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026